Skip to main content

Now Most UK Cases

Sharon Peacock, the director of COVID-19 Genomics UK, says the B.1.1.7 variant of SARS-CoV-2 has taken over there, Reuters reports.

Health officials in the UK sounded the alert about the B.1.1.7 SARS-CoV-2 variant in December, and subsequent studies have suggested that the B.1.1.7 variant — which was first detected in the UK in September 2020, according to Reuters — is about 50 percent more transmissible than previous viral variants and a recent study has suggested it may also be more deadly.

In an online briefing for the Royal Society of Medicine, Peacock said the B.1.1.7 variant is now widespread in the UK, according to Reuters. "We now know that it has spread across the UK and causes nearly all of the cases of COVID-19 — about 98 percent," she said. "It appears to be the case that the other variants are not getting a foothold in this country."

Reuters notes that the B.1.1.7 variant has since been uncovered in countries around the world, including the US. Peacock added that she expects the variant will expand quickly wherever it is found, according to Reuters.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.